Entheon Biomedical Corp.
ENBI
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -256.90K | -279.20K | -233.20K | -226.20K | -250.10K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.90K | -- | -- | -3.90K | 2.20K |
| Change in Net Operating Assets | -23.40K | 11.00K | -27.80K | 1.90K | -12.70K |
| Cash from Operations | -278.60K | -268.40K | -261.10K | -228.20K | -260.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 6.90K | 18.20K |
| Cash from Investing | -- | -- | -- | 6.90K | 18.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 500.00K | 647.50K | 147.50K | 147.50K | 147.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 349.40K | 457.60K | 108.20K | 108.20K | 108.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -9.30K |
| Net Change in Cash | 70.80K | 189.20K | -152.90K | -113.10K | -143.50K |